Michigan cannabis regulator suspends licenses held by producer of Muha Meds products

Michigan's Cannabis Regulatory Agency on Wednesday suspended the licenses held by a Pinconning-based processor whose products are marketed under the brand Muha Meds after determining that the health and safety of its customers were jeopardized by its continued operation.

The final products — which include vape cartridges, infused pre-rolled joints and gummies — passed compliance testing but were unable to be traced back to regulated packages of marijuana flower and concentrate used for their production, the CRA said in a public health and safety bulletin. Therefore, the safety of the products can't be ensured, the agency said.

The CRA's investigation revealed that Michigan Investments 10 Inc. incorrectly entered data into the statewide monitoring system (Metrc), failed to properly track large quantities of product in Metrc, had products that were missing Metrc tags and could not be traced to the legal market and could not physically locate a number of products that were in their Metrc inventory, the CRA said in an email to stakeholders.

The company failed to produce proper quantities of product for sampling to be tested and failed to properly enter test results into Metrc, the CRA said. Products tested at different stages showed inconsistent results, the agency said.

In an emailed statement sent from Michigan Investments 10 employee Jenna Mullins on behalf of the company's management team, Michigan Investments 10 said it took action to comply with the issues the CRA found that led the agency to place an administrative hold on the company's products in September.

The company said in the statement that the CRA permitted the company to resume operations after the company addressed the agency's concerns but then the CRA suspended its licenses.

The company also said in the statement that it "remains steadfast in its defense against these actions and will continue to engage with the CRA to seek clarity on their requirements and expedite the reopening of our facility."

"Our commitment to providing exceptional cannabis products and services remains unchanged, and we are hopeful for a swift resolution to this matter," the company's statement said. "Muha Meds and Michigan Investments 10 stand behind every one of our products."

Muha Meds, founded in 2018 in California, entered the Michigan market two years ago, according to a news release. Muha Meds selected Michigan for the location of its first licensed manufacturing operation "due to its welcoming retail climate and business-friendly tax policies."

Muha Meds products are sold at 99 dispensaries across Michigan, according to a store locator tool on Muha Med's website.

More cannabis industry news:Michigan recalls cannabis-infused apple cider after reports of cans bursting

More cannabis industry news:Detroit awards 37 recreational marijuana licenses for retail, consumption lounges

Customers who have experienced adverse reactions after using these products should report their symptoms and product use to their health care providers, the CRA said.

Consumers are also encouraged to report any adverse reactions to the products to the CRA via email at CRA-Enforcement@michigan.gov or by calling 517-284-8599.

For more information, visit Michigan.gov/CRA/bulletins.

Contact Adrienne Roberts: amroberts@freepress.com.